Generate Investment Trims Elevance Health Holdings

The institutional investor reduced its stake in the healthcare company by 87% in Q4 2025.

Mar. 28, 2026 at 10:28am

Got story updates? Submit your updates here. ›

Generate Investment Management Ltd. trimmed its position in Elevance Health, Inc. (NYSE: ELV) by 87.0% in the fourth quarter of 2025, according to a recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,500 shares of the company's stock at the end of the reporting period.

Why it matters

Elevance Health is one of the largest healthcare and insurance providers in the United States, so changes to major institutional investors' holdings can signal broader trends in the sector and the company's performance.

The details

Generate Investment Management reduced its stake in Elevance Health from 135,000 shares to just 17,500 shares during the fourth quarter of 2025. The firm's holdings in the company were valued at $6.14 million at the end of the reporting period.

  • Generate Investment Management filed its 13F report for Q4 2025 on March 28, 2026.

The players

Generate Investment Management Ltd

An institutional investment firm that manages over $6 billion in assets.

Elevance Health, Inc.

A large U.S. health benefits company that provides a broad range of insurance products and related services.

Got photos? Submit your photos here. ›

The takeaway

This filing indicates that Generate Investment Management has reduced its exposure to Elevance Health, potentially signaling a broader shift in investor sentiment around the healthcare sector or the company's performance. However, without additional context, it's difficult to draw firm conclusions about the reasons behind the portfolio change.